Rothschild Asset Management Inc. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,582 shares of the medical research company’s stock, valued at approximately $628,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Skandinaviska Enskilda Banken AB publ increased its stake in shares of Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares during the last quarter. British Columbia Investment Management Corp increased its stake in shares of Agilent Technologies by 96.7% in the first quarter. British Columbia Investment Management Corp now owns 357,983 shares of the medical research company’s stock valued at $18,927,000 after buying an additional 175,992 shares during the last quarter. Wesbanco Bank Inc. bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $215,000. Creative Planning increased its stake in shares of Agilent Technologies by 6.3% in the first quarter. Creative Planning now owns 11,961 shares of the medical research company’s stock valued at $632,000 after buying an additional 710 shares during the last quarter. Finally, Henderson Group PLC increased its stake in shares of Agilent Technologies by 2.2% in the first quarter. Henderson Group PLC now owns 37,408 shares of the medical research company’s stock valued at $1,978,000 after buying an additional 800 shares during the last quarter.

Agilent Technologies, Inc. (NYSE:A) opened at 58.57 on Friday. The firm has a market capitalization of $18.82 billion, a PE ratio of 32.92 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $61.84. The stock has a 50 day moving average of $60.14 and a 200 day moving average of $55.60.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period last year, the business earned $0.44 earnings per share. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. On average, equities analysts predict that Agilent Technologies, Inc. will post $2.23 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd were given a $0.132 dividend. The ex-dividend date was Thursday, June 29th. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.90%. Agilent Technologies’s dividend payout ratio (DPR) is currently 29.78%.

WARNING: This piece of content was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/11/rothschild-asset-management-inc-takes-position-in-agilent-technologies-inc-a.html.

Several analysts recently commented on the stock. Jefferies Group LLC lifted their target price on shares of Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a report on Tuesday, May 23rd. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Deutsche Bank AG lifted their target price on shares of Agilent Technologies from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Monday, May 22nd. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $42.92 to $60.73 in a report on Wednesday, July 12th. Finally, Cowen and Company lifted their target price on shares of Agilent Technologies from $53.00 to $62.00 and gave the stock a “market perform” rating in a report on Tuesday, May 23rd. Two equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $60.12.

In other news, insider Mark Doak sold 21,851 shares of the firm’s stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $60.00, for a total value of $1,311,060.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the transaction, the insider now owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The disclosure for this sale can be found here. Insiders sold 112,608 shares of company stock valued at $6,737,509 over the last 90 days.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.